{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:59:16Z","timestamp":1781513956687,"version":"3.54.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82574998"],"award-info":[{"award-number":["82574998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH394"],"award-info":[{"award-number":["ZR2021MH394"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong Province Traditional Chinese Medicine Science and Technology Project","award":["M-2022265"],"award-info":[{"award-number":["M-2022265"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>To analyze erythropoietin (EPO) secretion and bone marrow proliferation under conditions of renal anemia with varying degrees of kidney injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>First, a cross-sectional analysis compared serum EPO levels between patients with early-stage chronic kidney disease (CKD stages 1\u20132) and those with advanced CKD (stage 5) who had not undergone hemodialysis or received EPO therapy [CKD5 + non-hemodialysis (non-HD)]. Bone marrow hyperplasia of two patients from each group was analyzed using Wright-Giemsa staining. Second, two C57BL\/6 mouse models of progressive renal anemia were established using adenine gavage with or without unilateral pedicle ligation (8M\u2013N: control; 8M\u2013M: adenine + sham; 8M\u2013NM: adenine + ligation). Renal and hepatic EPO expression, bone marrow EPOR and CD71 levels, CpG island methylation in the EPO promoter, and erythroid differentiation by flow cytometry were analyzed, etc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to CKD stage 1\u20132 patients, the CKD5\u00a0+\u00a0non-HD group showed significantly lower hemoglobin, estimated glomerular filtration rate, and higher creatinine and BUN levels (P\u00a0&amp;lt;\u00a0.001). Serum EPO concentrations showed no significant differences between patient groups or experimental mouse groups with varying degrees of kidney injury (P\u00a0&amp;gt;\u00a0.05). However, the proportion of nucleated cells to mature erythrocytes and erythroid precursors to bone marrow nucleated cells was markedly reduced in CKD5\u00a0+\u00a0non-HD patients compared to CKD1-2 patients (P\u00a0&amp;lt;\u00a0.05). In animal models with progressive kidney injury (normal controls, adenine\u00a0+\u00a0sham, and adenine\u00a0+\u00a0unilateral pedicle ligation), serum creatinine, renal fibrosis as assessed by MASSON\/PASM staining, CpG island methylation in the EPO promoter and hepatic EPO expression were gradually elevated (P\u00a0&amp;lt;\u00a0.05). In contrast, hemoglobin, hematocrit, and marrow EPOR\/CD71 levels and the proportions of Ter119+ nucleated erythroid cells declined progressively with worsening renal injury (8M-N\u00a0&amp;gt;\u00a08M-M\u00a0&amp;gt;\u00a08M-NM, P\u00a0&amp;lt;\u00a0.001), and the proportions of CD44low\/CD711ow late erythroid precursors within Ter119+ nucleated erythroid cells was significantly reduced in 8M-NM (P\u00a0&amp;lt;\u00a0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In renal anemia, compensatory EPO production from extrarenal tissues may partially offsets the reduction in systemic EPO levels. However, bone marrow proliferation, particularly erythroid hematopoiesis, is significantly impaired, highlighting the critical impact of reduced erythropoiesis on anemia progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag111","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:06:42Z","timestamp":1778760402000},"source":"Crossref","is-referenced-by-count":0,"title":["Unmasking erythroid suppression: the hidden culprit in renal anemia pathogenesis"],"prefix":"10.1093","author":[{"given":"Jiawei","family":"Yu","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Hematology Department, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zibo Fourth People\u2019s Hospital Traditional Chinese Medicine Department, , Zibo ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhentao","family":"Guo","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxin","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1706-4417","authenticated-orcid":false,"given":"Xiangming","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong Second Medical University Nephrology Department & Weifang Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic renal Failure Prevention, , Weifang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026061504511945500_bib1","doi-asserted-by":"publisher","first-page":"e3872","DOI":"10.1097\/MD.0000000000003872","article-title":"Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026061504511945500_bib2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"2026061504511945500_bib3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10157-019-01767-w","article-title":"Treatment for renal anemia and outcomes in non-dialysis patients with chronic kidney disease: the current status of regional medicine according to the Kyoto Fushimi Renal Anemia (KFRA) study","volume":"23","author":"Yahata","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2026061504511945500_bib4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/ckj\/sfaa054","article-title":"Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis","volume":"13","author":"Evans","year":"2020","journal-title":"Clin Kidney J"},{"key":"2026061504511945500_bib5","first-page":"Cd010590","article-title":"Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis","volume":"2014","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026061504511945500_bib6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"key":"2026061504511945500_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000496369","article-title":"Iron metabolism in chronic kidney disease patients","volume":"198","author":"Honda","year":"2019","journal-title":"Contrib Nephrol"},{"key":"2026061504511945500_bib8","first-page":"83030","article-title":"The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease","author":"CJ","year":"2017","journal-title":"Oncotarget"},{"key":"2026061504511945500_bib9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000350141","article-title":"The uremic toxin acrolein promotes suicidal erythrocyte death","volume":"37","author":"Ahmed","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"2026061504511945500_bib10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/ndt\/gfad250","article-title":"Anaemia in CKD-treatment standard","volume":"39","author":"Macdougall","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026061504511945500_bib11","doi-asserted-by":"publisher","first-page":"e918643","DOI":"10.12659\/MSM.918643","article-title":"Age-related decline in renal blood flow could be a beneficial and compensatory mechanism","volume":"26","author":"Czarkowska-P\u0105czek","year":"2020","journal-title":"Med Sci Monit"},{"key":"2026061504511945500_bib12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1523-1755.2004.00880.x","article-title":"Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia","volume":"66","author":"Fehr","year":"2004","journal-title":"Kidney Int"},{"key":"2026061504511945500_bib13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00424-022-02714-7","article-title":"Fount, fate, features, and function of renal erythropoietin-producing cells","volume":"474","author":"Dahl","year":"2022","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"2026061504511945500_bib14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphys.2015.00167","article-title":"Renal erythropoietin-producing cells in health and disease","volume":"6","author":"Souma","year":"2015","journal-title":"Front Physiol"},{"key":"2026061504511945500_bib15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jemt.1070250106","article-title":"The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver","volume":"25","author":"Koury","year":"1993","journal-title":"Microsc Res Tech"},{"key":"2026061504511945500_bib16","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026061504511945500_bib17","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1172\/JCI57301","article-title":"Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice","volume":"121","author":"Asada","year":"2011","journal-title":"J Clin Invest"},{"key":"2026061504511945500_bib18","doi-asserted-by":"publisher","first-page":"e13768","DOI":"10.1111\/apha.13768","article-title":"Fate-mapping of erythropoietin-producing cells in mouse models of hypoxaemia and renal tissue remodelling reveals repeated recruitment and persistent functionality","volume":"234","author":"Dahl","year":"2022","journal-title":"Acta Physiologica"},{"key":"2026061504511945500_bib19","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1159\/000502525","article-title":"Red blood cell lifespan shortening in patients with early-stage chronic kidney disease","volume":"44","author":"Li","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"2026061504511945500_bib20","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1007\/s11255-024-04146-x","article-title":"Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis","volume":"56","author":"Yuan","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"2026061504511945500_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Clinical practice guideline for the management of glomerular diseases","volume":"100","author":"KDIGO 2021","year":"2021","journal-title":"Kidney Int"},{"key":"2026061504511945500_bib22","doi-asserted-by":"publisher","DOI":"10.3791\/2809","article-title":"Identification and analysis of mouse erythroid progenitors using the CD71\/TER119 flow-cytometric assay","author":"Koulnis","year":"2011;(54):2809.","journal-title":"J Vis Exp"},{"key":"2026061504511945500_bib23","doi-asserted-by":"publisher","first-page":"122641","DOI":"10.1016\/j.lfs.2024.122641","article-title":"The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction","volume":"346","author":"Nakai","year":"2024","journal-title":"Life Sci"},{"key":"2026061504511945500_bib24","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/bloodadvances.2023009798","article-title":"Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice","volume":"7","author":"Nakai","year":"2023","journal-title":"Blood Adv"},{"key":"2026061504511945500_bib25","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1093\/eurheartj\/ehad235","article-title":"Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors","volume":"44","author":"Packer","year":"2023","journal-title":"Eur Heart J"},{"key":"2026061504511945500_bib26","first-page":"505","article-title":"Erythropoietin: indications and measurement]","volume":"67","author":"Klein","year":"2009","journal-title":"Ann Biol Clin (Paris)"},{"key":"2026061504511945500_bib27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/sctm.17-0158","article-title":"Role of CD133 molecule in Wnt response and renal repair","volume":"7","author":"Brossa","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"2026061504511945500_bib28","doi-asserted-by":"publisher","first-page":"F658","DOI":"10.1152\/ajprenal.00243.2019","article-title":"Perivascular CD73(+) cells attenuate inflammation and interstitial fibrosis in the kidney microenvironment","volume":"317","author":"Perry","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026061504511945500_bib29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1172\/JCI82819","article-title":"DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys","volume":"126","author":"Chang","year":"2016","journal-title":"J Clin Invest"},{"key":"2026061504511945500_bib30","first-page":"326","article-title":"Down-regulation of cardiac erythropoietin receptor and its downstream activated signal transducer phospho-STAT-5 in a rat model of chronic kidney disease","volume":"18","author":"Hertzberg-Bigelman","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"2026061504511945500_bib31","doi-asserted-by":"publisher","first-page":"110583","DOI":"10.1016\/j.cellsig.2022.110583","article-title":"Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease","volume":"104","author":"Hamza","year":"2023","journal-title":"Cell Signalling"},{"key":"2026061504511945500_bib32","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1182\/blood.2021011044","article-title":"Molecular and cellular mechanisms that regulate human erythropoiesis","volume":"139","author":"Caulier","year":"2022","journal-title":"Blood"},{"key":"2026061504511945500_bib33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra1804281","article-title":"Anemia of inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag111\/68322475\/gfag111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag111\/68322475\/gfag111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:51:24Z","timestamp":1781513484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag111\/8684981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag111","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"gfag111"}}